Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder
Clinical trial NCT00755040 · COMPLETED
Trial details
- NCT number
- NCT00755040
- Sponsor
- Vanderbilt-Ingram Cancer Center
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-10-01
- Primary completion
- 2014-12-01
- Enrollment
- 164
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.